Renaturation, purification, and characterization of human plasminogen activator inhibitor type 2 (PAI-2) accumulated at high level in Escherichia coli

Journal of Biochemistry

Volumn 121, Issue 5, 1997, Pages 930-934

  Zhou, Aiwu ^a   Jiang, Xueyuan ^a   Dou, Fei ^a   Zhu, Dexu ^a   Xu, Xianxiu ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Gene expression; Inclusion body; Plasminogen activator inhibitor 2 (PAI 2); Renaturation; Serine protease inhibitor (SERPIN)

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 2; RECOMBINANT PROTEIN;

ARTICLE; BACTERIOPHAGE T7; CONTROLLED STUDY; ESCHERICHIA COLI; HUMAN; NONHUMAN; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RECOMBINANT GENE; RENATURATION;

EID: 0030994419     PISSN: 0021924X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.jbchem.a021675     Document Type: Article

References (26)

1. Travis, J. and Salvesen, G.S. (1983) Human plasma proteinase inhibitors. Annu. Rev. Biochem. 52, 655-709
2. van Mourik, J.A., Lawrence, D.A., and Loskutoff, D.J. (1984) Purification of an inhibitor of plasminogen activator synthesized by endothelial cells. J. Biol. Chem. 259, 14914-14921
3. Astedt, B., Lecander, I., and Ny, T. (1987) The placental type plasminogen activator inhibitor, PAI-2. Fibrinolysis 1, 203-208
4. Baker, J.B., Low, D.A., Simmer, R.L., and Cunningham, D.D. (1980) Proteinase Nexin, a cellular component that links thrombin and plasminogen activator and mediates their binding to cells. Cell 21, 37-45
5. Danø, K., Andreasen, P.A., and Grondahl-Hansen, J. (1985) Plasminogen activators, tissue degradation and cancer. Adv. Cancer Res. 44, 139-166
6. Testa, J.E. and Quigley, J.P. (1990) The role of urokinase-type plasminogen activator in aggressive tumor cell behavior. Cancer Metas. Rev. 9, 353-367
7. Kruithof, E.K.O., Vassalli, J.D., Schleuning, W.D., Mattaliano, R.J., and Bachmann, F. (1986) Purification and characterization of plasminogen activator inhibitor from histiocytic lymphoma cell line U-937. J. Biol. Chem. 261, 11207-11213
8. Kawata, Y., Mimuro, J., Kaneko, M., Shimada, K., and Sakata, Y. (1996) Expression of plasminogen activator inhibitor 2 in the adult and embryonic mouse tissues. Thromb. Haemostas. 76, 569-576
9. Astedt, B., Hagerstrand, I., and Lecander, I. (1986) Cellular localization in placenta of placental type plasminogen activator inhibitor. Thromb. Haemostas. 56, 63-65
10. Vassali, J.D., Dayer, J.M., Wohlwend, A., and Belin, D. (1984) Concomitant secretion of prourokinase and a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages. J. Exp. Met. 159, 1653-1668
11. Ye, R.D., Wun, T.C., and Sadler, J.E. (1987) cDNA cloning and expression in E. coli of plasminogen activator inhibitor from human placenta. J. Biol. Chem. 262, 3718-3725
12. Ye, R.D., Wun, T.C., and Sadler, J.E. (1988) Mammalian protein secretion without signal peptide removal. Biosynthesis of plasminogen activator inhibitor-2 in U-937 cells. J. Biol. Chem. 263, 4869-4875
13. Genton, C., Kruithof, E.K.O., and Schleuning, W.D. (1987) Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells. J. Cell Biol. 165, 320-339
14. Mikus, P. and Ny, T. (1990) Intracellular polymerization of the serpin plasminogen activator inhibitor type 2. J. Biol. Chem. 271, 10048-10053
15. Wu, T.C. and Reich, E. (1987) An inhibitor of plasminogen activation from human placenta. J. Biol. Chem. 262, 3646-3653
16. Yei, P., Zhou, A.W., Cao, X.R., and Xu, X.X. (1995) Expression of human plasminogen activator inhibitor-2 in the baculovirus expression system. Biochem. Mol. Biol. Int. 35, 923-928
17. Steven, J., Cottingham, I.R., Berry, S.J., Chinery, S.A., Goddey, A.R., Courtney, M., and Ballance, D.J. (1991) Purification and characterization of plasminogen activator inhibitor type 2 produced in Saccharomyces cerervisiae. Eur. J. Biochem. 196, 431-438
18. Mikus, P., Urano, T., Liljestrom, P., and Ny, T. (1993) Plasminogen activator inhibitor type 2 is a spontaneously polymerising SERPIN. Eur. J. Biochem. 218, 1071-1082
19. Zeng, M., Huang, B.R., and Lapeyre, J.N. (1996) Cloning strategies using a third irrelevant enzyme site to overcome certain problems. BioTechniques 20, 68-78
20. Mark, D.F., Wang, A., and Levenson, C. (1987) Site specific mutagenesis to modify the human tumor necrosis factor gene. Methods Enzymol. 154, 403-414
21. Chmielewska, J., Ranby, M., and Wiman, B. (1988) Kinetics of the inhibition of plasminogen activators by plasminogen activator inhibitor. Biochem. J. 251, 327-332
22. Bradford, M.M. (1976) A rapid sensitive method for the quantitation of micrograms of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254
23. Guo, D.L., Shen, B.H., Dong, X.Y., and Xu, X.X. (1995) Creation of high cytotoxic active human tumor necrosis factor having the truncated and more basic amino terminus. Biochem. Biophy. Res. Commun. 207, 927-932
24. Zhang, L., Cao, X.R., Peng, S.M., and Xu, X.X. (1996) Overproduction of metastatic suppresser gene nm23-1 in E. coli and its activity measurement. J. Nanjing Univ. 32, 262-267
25. Zhou, A.W., Pei, Y., Wu, H.H., Dong, X.Y., and Xu, X.X. (1996) High-level expression of active human plasminogen activator inhibitor type 1 (PAI-1) in E. coli. Biochem. Mol. Biol. Int. 39, 235-242
26. Jiang, X.Y., Li, S.Q., Zhou, A.W., Li, F.Q., Xu, X.X., and Zhu, D.X. (1996) Translation initiation region plays an important role in the expression of human thrombopoietin in E. coli. Biochem. Mol. Biol. Int. 39, 1109-1113